Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
A-Alpha Bio
3189
A-Alpha Bio
Technology
Biotechnology
Research
AAlpha Bio is revolutionizing preclinical drug development. Our technology enables unprecedented characterization of proteinprotein interactions.
Suggest edits
Type
B2c
Founded
2017
Raised
$1M
Follow us
Also headquartered in Seattle
Amazon
GeekWire
Starbucks
Amazon Web Services
Zillow
Redfin
Tableau
Gates Foundation
Bittrex
Bungie
Companies in the same industry
Illumina
Restored Hearing
Beijing Gene+ Technology
New Harvest
International Peptides
CereVasc
Benchling
Toxys
Biophytis
Sano Genetics
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Latest funding
$800,000
Grant - 2020
Bill & Melinda Gates Foundation
$225,000
Grant - 2018
National Science Foundation (NSF)
Team Size
1–10
Employees
I work here
Location
Seattle
,
United States
Headquarters
Explore Seattle
$800,000
Grant
GeekWire
,
neurons.AI
Gates Foundation awards $800K grant to A-Alpha Bio for COVID-19 treatment research
$225,000
Grant
GeekWire
Clinical drug screening startup A-Alpha Bio awarded Small Business Innovation Research grant
GeekWire
Pre-clinical drug screening startup A-Alpha Bio wins first place at Univ. of Washington Business Plan Competition
Robotics
